Their meaning was established in the pathogenesis of NDs and psoriasis, and there have been clinical trials with RIP1 inhibitors as potential drugs started a while ago (Harris et al., 2019; Newton, 2020). This evidence concerns the gene RIPK1 and psoriasis.